OrthoPediatrics (KIDS) Expected to Announce Earnings on Tuesday

OrthoPediatrics (NASDAQ:KIDSGet Free Report) is expected to be announcing its earnings results after the market closes on Tuesday, March 4th. Analysts expect the company to announce earnings of ($0.22) per share and revenue of $51.16 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS opened at $23.49 on Tuesday. The firm has a market cap of $568.83 million, a P/E ratio of -19.10 and a beta of 1.14. The business’s 50 day moving average is $24.32 and its 200-day moving average is $26.08. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. OrthoPediatrics has a 1-year low of $21.02 and a 1-year high of $35.99.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Truist Financial reduced their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Tuesday, January 14th.

Check Out Our Latest Research Report on KIDS

OrthoPediatrics Company Profile

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Read More

Earnings History for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.